The impact of the COVID-19 pandemic on perioperative chemotherapy for breast cancer.
Sign Up to like & getrecommendations! Published in 2023 at "Cancer medicine"
DOI: 10.1002/cam4.5898
Abstract: BACKGROUND Since it was first reported in December 2019, coronavirus disease 2019 (COVID-19) spread rapidly across the globe resulting in a pandemic. As of August 2022, seven outbreak peaks have been confirmed in Tokyo, and… read more here.
Keywords: impact covid; perioperative chemotherapy; covid pandemic; chemotherapy ... See more keywords
Perioperative chemotherapy for resectable colorectal liver metastases: Analysis from the Colorectal Operative Liver Metastases International Collaborative (COLOMIC)
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Surgical Oncology"
DOI: 10.1002/jso.26893
Abstract: Chemotherapy has been increasingly combined with surgery as multimodality treatment for resectable colorectal‐liver metastases (CLM). There is paucity of clinical data addressing optimal timing of chemotherapy relative to surgery. We examined outcomes of patients undergoing… read more here.
Keywords: liver; resectable colorectal; perioperative chemotherapy; colorectal liver ... See more keywords
PD‐L1 expression in gastric and gastroesophageal junction cancer patients treated with perioperative chemotherapy
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Surgical Oncology"
DOI: 10.1002/jso.26929
Abstract: The incidence, predictive, and prognostic impact of programmed cell death (PD‐L1) expression in gastric (GC) and gastroesophageal junction tumors (GEJC) treated with perioperative chemotherapy is poorly understood. We aimed to assess PD‐L1 expression by immunohistochemistry… read more here.
Keywords: treated perioperative; gastroesophageal junction; expression; perioperative chemotherapy ... See more keywords
Cytidine Deaminase Activity Assessment to Select Perioperative Chemotherapy Regimen in Localized Bladder Cancer
Sign Up to like & getrecommendations! Published in 2017 at "Clinical Genitourinary Cancer"
DOI: 10.1016/j.clgc.2017.01.017
Abstract: The optimal perioperative chemotherapy regimen in localized bladder cancer is still unknown. The cisplatin-gemcitabine regimen is a reasonable alternative to accelerated methotrexate, vincristine, cisplatin, and adriamycin in this setting in terms of efficacy. Gemcitabine is… read more here.
Keywords: chemotherapy regimen; regimen localized; perioperative chemotherapy; cancer ... See more keywords
Perioperative chemotherapy for resectable gastric cancer – what is the evidence?
Sign Up to like & getrecommendations! Published in 2017 at "Scandinavian Journal of Gastroenterology"
DOI: 10.1080/00365521.2017.1293727
Abstract: Abstract The UK MAGIC trial published in 2006 was the first RCT to identify improved long-term survival rates using preoperative chemotherapy for resectable gastric or gastroesophageal cancer. Overnight, the treatment regimen impacted European guidelines. However,… read more here.
Keywords: chemotherapy; resectable gastric; survival rates; perioperative chemotherapy ... See more keywords
Real-world evidence on perioperative chemotherapy in localized soft tissue sarcoma of the extremities and trunk wall; a population-based study
Sign Up to like & getrecommendations! Published in 2022 at "Acta Oncologica"
DOI: 10.1080/0284186x.2022.2082259
Abstract: Abstract Background Data from the real-world setting on perioperative chemotherapy in high-risk, localized soft tissue sarcoma (STS) is limited. Real-world data (RWD) includes data derived from patients treated outside clinical trials and often captures long-term… read more here.
Keywords: perioperative chemotherapy; real world; cohort; chemotherapy ... See more keywords
Health-related quality of life following neoadjuvant chemoradiotherapy versus perioperative chemotherapy and esophagectomy for esophageal cancer: a European multicenter study
Sign Up to like & getrecommendations! Published in 2022 at "Diseases of the Esophagus"
DOI: 10.1093/dote/doac069
Abstract: Summary Curative treatment for locally advanced esophageal cancer consists of (neo)adjuvant treatment followed by esophagectomy. Both neoadjuvant chemoradiotherapy and perioperative chemotherapy improve the 5-year overall survival rate compared with surgery alone. However, it is unknown… read more here.
Keywords: neoadjuvant chemoradiotherapy; perioperative chemotherapy; chemotherapy; treatment ... See more keywords
Role of perioperative chemotherapy and radiotherapy for localized high-grade malignant peripheral nerve sheath tumor at the extremities and trunk wall: a population-based cohort study.
Sign Up to like & getrecommendations! Published in 2022 at "Japanese journal of clinical oncology"
DOI: 10.1093/jjco/hyac178
Abstract: BACKGROUND Primary tumor resection is the mainstay of treatment for malignant peripheral nerve sheath tumors. However, the efficacy of perioperative chemotherapy and radiotherapy for malignant peripheral nerve sheath tumors has not been elucidated. METHODS This… read more here.
Keywords: perioperative chemotherapy; disease specific; overall survival; specific overall ... See more keywords
Fong’s Score in the Era of Modern Perioperative Chemotherapy for Metastatic Colorectal Cancer: A Post Hoc Analysis of the GERCOR-MIROX Phase III Trial
Sign Up to like & getrecommendations! Published in 2019 at "Annals of Surgical Oncology"
DOI: 10.1245/s10434-019-07976-7
Abstract: Background Despite improvement in colorectal liver metastasis (CLM) treatment, survival after liver surgery remains highly variable. Several clinicopathologic prognostic factors have been reported, but their validity in the era of more effective perioperative chemotherapy remains… read more here.
Keywords: chemotherapy; analysis; perioperative chemotherapy; iii trial ... See more keywords
Putting guidelines into practice: has the era of perioperative chemotherapy arrived?
Sign Up to like & getrecommendations! Published in 2018 at "Translational Andrology and Urology"
DOI: 10.21037/tau.2018.04.02
Abstract: In the current landscape of bladder cancer management, marked survival differences exist between non-muscle invasive, muscle invasive and metastatic disease (5-year survival 95%, 50% and 6%, respectively) (1). The rationale for a multi-modal approach to… read more here.
Keywords: era perioperative; putting guidelines; guidelines practice; practice era ... See more keywords